Rashmi S Goswami
Overview
Explore the profile of Rashmi S Goswami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olkhov-Mitsel E, Chan D, Craddock K, Lin A, Luk G, Goswami R, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682116
Background: Targeted next-generation sequencing (NGS) panels are increasingly being utilized to identify actionable gene amplifications (copy number > 4) among solid tumors. Methods: This study validated the analytical performance of...
2.
Bahlmann L, Xue C, Chin A, Skirzynska A, Lu J, Theriault B, et al.
Biomaterials
. 2023 Apr;
297:122121.
PMID: 37075613
Tumour-associated macrophages are linked with poor prognosis and resistance to therapy in Hodgkin lymphoma; however, there are no suitable preclinical models to identify macrophage-targeting therapeutics. We used primary human tumours...
3.
Stubbins R, Lam R, Zhu J, Ghosh S, Mabilangan C, Kuruvilla J, et al.
Clin Lymphoma Myeloma Leuk
. 2022 Jun;
22(10):744-752.
PMID: 35717340
Introduction: The tumor microenvironment (TME) in post-transplant lymphoproliferative disorders (PTLDs) remains unexplored. Tumor infiltrating lymphocytes (TILs) are prognostic in other lymphomas. We assessed the prognostic impact of TILs in monomorphic...
4.
Velu P, Cushman-Vokoun A, Ewalt M, Feilotter H, Gastier-Foster J, Goswami R, et al.
J Mol Diagn
. 2022 Jun;
24(8):825-840.
PMID: 35690309
In the two decades since Accreditation Council for Graduate Medical Education-accredited Molecular Genetic Pathology fellowships began, the field of clinical molecular pathology has evolved considerably. The American Board of Pathology...
5.
Beck R, Kim A, Goswami R, Weinberg O, Yeung C, Ewalt M
Am J Clin Pathol
. 2020 May;
154(2):149-177.
PMID: 32444878
Objectives: At a discussion on molecular/cytogenetic education for hematopathology fellows at the 2018 Society for Hematopathology Program Directors Meeting, consensus was that fellows should understand basic principles and indications for...
6.
Goswami R, Harada S
Curr Protoc Hum Genet
. 2020 Feb;
105(1):e97.
PMID: 32105409
Our understanding of genetic disease(s) has increased exponentially since the completion of human genome sequencing and the development of numerous techniques to detect genetic variants. These techniques have not only...
7.
Reis P, Tokar T, Goswami R, Xuan Y, Sukhai M, Seneda A, et al.
Sci Rep
. 2020 Feb;
10(1):1713.
PMID: 32015424
Prognostic biomarkers for recurrence of Oral Squamous Cell Carcinoma (OSCC) are urgently needed. We aimed to independently validate a 4-gene expression signature (MMP1, COL4A1, P4HA2, THBS2) predictive of OSCC recurrence...
8.
Croci G, Hoster E, Bea S, Clot G, Enjuanes A, Scott D, et al.
Virchows Arch
. 2020 Jan;
477(2):259-267.
PMID: 31975037
Mantle cell lymphoma (MCL) shows a clinical aggressiveness that varies from patient to patient. Despite major advances in outcomes with current immunochemotherapy, the future development of therapies requires risk stratification...
9.
Goswami R, Luthra R, Singh R, Patel K, Routbort M, Aldape K, et al.
Am J Clin Pathol
. 2016 Apr;
145(2):222-37.
PMID: 27124905
Objectives: Clinical laboratories are rapidly implementing next-generation sequencing (NGS) tests for mutation analysis, but there are few guidelines regarding sample quality for successful results. Methods: We aimed to establish tissue...
10.
Goswami R, Wang S, DiNardo C, Tang Z, Li Y, Zuo W, et al.
Mod Pathol
. 2016 Apr;
29(7):727-34.
PMID: 27056073
Deletion 7q is a common chromosomal abnormality in myeloid neoplasms. Detection of del(7q) in patients following cytotoxic therapies is highly suggestive of an emerging therapy-related myeloid neoplasm. In this study,...